The insulin-like growth factor system and its receptors: A potential novel anticancer target
Colin R. Lindsay1, T R Jeffry Evans1,21Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; 2University of Glasgow, CR-UK Beatson Laboratories, Garscube Estate, Glasgow, United KingdomAbstract: The current generation of novel anticancer therapies that are in preclinical and clinical deve...
Guardado en:
Autores principales: | Colin R. Lindsay, T R Jeffry Evans |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b44103bd7eed4cf18d00a23dd4b03d7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural basis of the activation of type 1 insulin-like growth factor receptor
por: Jie Li, et al.
Publicado: (2019) -
How ligand binds to the type 1 insulin-like growth factor receptor
por: Yibin Xu, et al.
Publicado: (2018) -
Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma.
por: Zheng Liang, et al.
Publicado: (2014) -
Association of Growth Velocity with Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Children with a Vegan Diet
por: Arie Purwana, et al.
Publicado: (2020) -
Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska HA, et al.
Publicado: (2015)